Inventor · disambiguated record
Pradeep Tyagi
Also filed as: TYAGI PRADEEP · TYAGI PRADEEP KUMAR
2 granted patents·8 pending applications·14 citations·filing 2006–2024
56Inventor score
Files withCHANCELLOR MICHAEL B2UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION2UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION2BEAUMONT HOSPITAL WILLIAM1DELITHE NATURAL PRODUCTS INC1
Top patents by PatentIndex Score
10 records- 0189US8110217B2Sphingomyelin liposomes for the treatment of hyperactive bladder disordersCHANCELLOR MICHAEL B·Filed 2006·Granted Feb 7, 2012·13 cites·9 claims
- 0269US10029012B2Peptide-mediated intravesical delivery of therapeutic and diagnostic agentsUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Granted Jul 24, 2018·1 cites·12 claims
- 0356US2018333496A1Peptide-mediated intravesical delivery of therapeutic and diagnostic agentsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2018·Application pending·0 cites
- 0455US2025135042A1Perfluorocarbon-Containing Contrast Agent for Use in MRI Imaging of Body CavitiesUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2024·Application pending·0 cites
- 0553US2012128762A1Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder DisordersCHANCELLOR MICHAEL B·Filed 2012·Application pending·0 cites
- 0651US2021052734A1Peptide-mediated intravesical delivery of therapeutic and diagnostic agentsTHE UNIV OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Application pending·0 cites
- 0749US2007028930A1Active agent and formulations to minimize or alleviate bladder urgency and irritation and/or to enhance sexual functionDELITHE NATURAL PRODUCTS INC·Filed 2006·Application pending·0 cites
- 0845US2017290773A1Sphingomyelin liposomes for the treatment of hyperactive bladder disordersUNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2017·Application pending·0 cites
- 0945US2016274126A1Biomarkers for the diagnosis of interstitial cystitisBEAUMONT HOSPITAL WILLIAM·Filed 2013·Application pending·0 cites
- 1039US2022251080A1Substantially pure venetoclax and amorphous venetoclax in a free drug particulat e formDr Reddys Laboratories Ltd·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →